Ensysce Biosciences, Inc. Deferred Costs, Noncurrent
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2022-08-11
- 2022-06-30: Deferred Costs, Noncurrent $82.82K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2022-06-30 | $82.82K 10-Q · filed 2022-08-11 |